ARCHIVES

In Brief: ACCC Lobbyists Got What They Wanted In House Cancer Act Bill; VA Group Review Set May 2

This article is from The Cancer Letter archive.

Vol. 04 No. 17 | April 28, 1978

Download PDF Visit The Full Archive

Related Articles

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

Part II of Q&A With NCI Director Harold Varmus

July 29, 2011

Cancer Patients Satisfied With Experience In Clinical Trials, Survey Of 2,000 Finds

July 28, 2006

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008

ACS Modifies Pap Test Guidelines

November 27, 1987

NCI’s Otis Brawley Named Professor At Emory, Associate Director, Cancer Control, At Winship.

April 20, 2001